Crispr Therapeutics Ag (CRSP)
$47.55 1.45 (3.15%)
17:43 EDT CRSP Stock Quote Delayed 15 Minutes
Previous Close $47.55
Market Cap 2.23B
PE Ratio -
Volume (Avg. Vol.) 374,100
Day's Range 45.82 - 47.99
52-Week Range 22.22 - 59.00
Dividend & Yield N/A (N/A)
CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News
- From InvestorPlace
- From the Web
Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.
CRSP is testing its gene editing therapies in sicke cell disease and cancer. These therapies could eventually boost CRSP stock.
No matter what risks you think lay ahead for the market (trade war, rate hikes, government shutdown), none of them hurt gene therapy stocks
The future of genetic medicine is bright, but bumpy. But these bumps will provide many opportunities to buy DNA stocks along the way.
Gene-editing technology is going to be a game-changer in the future, which means the time to invest in CRISPR stocks is now.
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd.
Although Crispr’s gene splicing techniques are revolutionary, the rally in CRSP stock is coming to an end as investors question its valuation.
Though the biotech industry is down this year, there are still a few stocks which can strengthen your portfolio. Compare Brokers....
Crispr stock is riding a euphoric wave thanks to the biotech firm’s innovations. But what is CRISPR and what are the downsides?
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!